• 1. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 2. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 4. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 5. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389

Recent Advances in the Study of tert-butyl 4-(ethylamino)piperidine-1-carboxylate (CAS: 264905-39-7) in Chemical Biology and Pharmaceutical Research

The compound tert-butyl 4-(ethylamino)piperidine-1-carboxylate (CAS: 264905-39-7) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, a piperidine derivative, serves as a crucial intermediate in the synthesis of various pharmacologically active compounds. Recent studies have highlighted its potential in drug discovery, particularly in the development of central nervous system (CNS) therapeutics and enzyme inhibitors. The versatility of this compound lies in its ability to act as a building block for more complex structures, making it a focal point in medicinal chemistry.

One of the most notable applications of tert-butyl 4-(ethylamino)piperidine-1-carboxylate is its role in the synthesis of kinase inhibitors. Kinases are enzymes that play a pivotal role in cell signaling and are often implicated in diseases such as cancer and inflammatory disorders. Researchers have utilized this compound to develop novel inhibitors that target specific kinase pathways, offering promising therapeutic avenues. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated the efficacy of derivatives of this compound in inhibiting aberrant kinase activity in vitro, with potential implications for targeted cancer therapies.

In addition to its applications in kinase inhibition, tert-butyl 4-(ethylamino)piperidine-1-carboxylate has been explored for its potential in CNS drug development. The piperidine moiety is a common feature in many CNS-active drugs due to its ability to cross the blood-brain barrier. Recent preclinical studies have shown that derivatives of this compound exhibit affinity for neurotransmitter receptors, suggesting their utility in treating neurological disorders such as depression and anxiety. A 2022 study in Bioorganic & Medicinal Chemistry Letters reported the synthesis of a series of analogs with improved selectivity for serotonin receptors, paving the way for further optimization.

The synthetic pathways for tert-butyl 4-(ethylamino)piperidine-1-carboxylate have also been a subject of recent research. Advances in green chemistry have led to the development of more sustainable and efficient methods for its production. For example, a 2023 paper in Organic Process Research & Development described a catalytic process that reduces waste and improves yield, addressing some of the environmental concerns associated with traditional synthetic methods. These innovations not only enhance the scalability of production but also align with the growing emphasis on sustainable practices in pharmaceutical manufacturing.

Despite these promising developments, challenges remain in the application of tert-butyl 4-(ethylamino)piperidine-1-carboxylate. Issues such as metabolic stability and bioavailability of its derivatives need to be addressed to fully realize their therapeutic potential. Ongoing research is focused on structural modifications to improve these properties, with computational modeling playing an increasingly important role in predicting the behavior of new analogs. Collaborative efforts between academia and industry are expected to drive further advancements in this area.

In conclusion, tert-butyl 4-(ethylamino)piperidine-1-carboxylate (CAS: 264905-39-7) represents a versatile and valuable compound in chemical biology and pharmaceutical research. Its applications in kinase inhibition and CNS drug development, coupled with advancements in synthetic methodologies, underscore its importance in modern drug discovery. Future research will likely focus on optimizing its derivatives for clinical use, addressing current limitations, and exploring new therapeutic targets. As such, this compound continues to be a key area of interest for researchers in the field.

• 75844-69-8(tert-butyl piperidine-1-carboxylate)
• 162167-97-7(Tert-butyl 3-(aminomethyl)piperidine-1-carboxylate)
• 147539-41-1(tert-butyl 4-(methylamino)piperidine-1-carboxylate)
• 184637-48-7(tert-butyl 3-aminopiperidine-1-carboxylate)
• 188111-79-7(tert-butyl (3R)-3-aminopiperidine-1-carboxylate)
• 207405-68-3(tert-butyl endo-3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate)
• 73874-95-0(4-Boc-Aminopiperidine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)